FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On September 11, 2006
Docket # Title
1995S-0316 75-Day Premarket Notifications for New Dietary Ingredients
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
2003D-0478 Guidance on Marketed Unapproved Drugs Compliance Policy Guide
2004E-0425 Patent Extension for Plenaxis (abarelix), U.S. Patent No. 5,843,901
2004E-0427 Patent Extension for Ketek (telithromycin), U.S. Patent No. 5,635,485
2005D-0195 Guidance for Industry and FDA Staff; The Mammography Quality Standards Act Final Regulations: Modifications and Additions to Policy Guidance Help System #9
2005E-0253 Patent Extension Application for TARCEVA (erlotinib hydrochloride), U.S. Patent No. 5,747,498
2006D-0331 Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
2006E-0008 Patent Extension Application for DRAXXIN (tulathromycin), U.S. Patent No. 6,420,536
2006E-0031 Patent Extension Application for CLOLAR (clofarabine), U.S. Patent No. 5,661,136
2006E-0050 Patent Extension Application for BYETTA (exenatide injection), U.S. Patent No. 5,424,286
2006E-0204 Patent Extension Application for NATRECOR (nesiritride) for U.S. Patent No. 5,114,923
2006P-0223 Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
2006P-0372 Determine whether Mepron (atovaquone) Tablets, 250 mg, has been voluntarily withdrawn from sale for safety or efficacy reasons
2006V-0373 Laser Light Show
1995S-0316 75-Day Premarket Notifications for New Dietary Ingredients
RPT 344 JLM Marketing Inc Vol #: 270
RPT 345 JLM Marketing Inc Vol #: 270
RPT 346 pH Sciences Vol #: 270
RPT 347 Health World, Inc Vol #: 270
RPT 348 Kaneka Corporation Vol #: 271
RPT 349 Pom Wonderful LLC Vol #: 270
RPT 350 Piscium International Vol #: 270
RPT 351 Seppie Inc Vol #: 270
RPT 352 Seppie Inc Vol #: 270
RPT 353 Seppie Inc Vol #: 270
SUP 16 Global Cancer Strategies Vol #: 270
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 18100 Integrative Therapeutics Inc Vol #: 167
LET 18101 Integrative Therapeutics Inc Vol #: 167
LET 18102 Nutrition Now Inc Vol #: 167
LET 18103 Flora Inc Vol #: 167
LET 18104 PuraPharm Corporation Vol #: 167
LET 18105 PuraPharm Corporation Vol #: 167
LET 18106 New Century Company Vol #: 167
LET 18107 Perrigo Company of South Carolina Vol #: 167
LET 18108 Perrigo Company of South Carolina Vol #: 167
LET 18109 Perrigo Company of South Carolina Vol #: 167
LET 18110 Perrigo Company of South Carolina Vol #: 167
LET 18111 Perrigo Company of South Carolina Vol #: 167
LET 18112 Perrigo Company of South Carolina Vol #: 167
LET 18113 Perrigo Company of South Carolina Vol #: 167
LET 18114 Perrigo Company of South Carolina Vol #: 167
LET 18115 Perrigo Company of South Carolina Vol #: 167
LET 18116 Perrigo Company of South Carolina Vol #: 167
LET 18117 Perrigo Company of South Carolina Vol #: 167
LET 18118 Perrigo Company of South Carolina Vol #: 167
LET 18119 Perrigo Company of South Carolina Vol #: 167
LET 18120 Perrigo Company of South Carolina Vol #: 167
LET 18121 Integrative Therapeutics Inc Vol #: 167
LET 18122 InteMedica LLC Vol #: 167
LET 18123 Lapte Enterprises, Inc dba Fruit Advantage Vol #: 167
LET 18124 Lapte Enterprises, Inc dba Fruit Advantage Vol #: 167
LET 18125 Lapte Enterprises, Inc dba Fruit Advantage Vol #: 167
LET 18126 Lipid Nutrition Vol #: 167
LET 18127 ECONET Inc dba Oasis LifeSciences Vol #: 167
LET 18128 Natural Factors Nutritional Products Inc Vol #: 167
LET 18129 Natural Factors Nutritional Products Inc Vol #: 167
LET 18130 Natural Factors Nutritional Products Inc Vol #: 167
LET 18131 Natural Factors Nutritional Products Inc Vol #: 167
LET 18132 Natural Factors Nutritional Products Inc Vol #: 167
LET 18133 Natural Factors Nutritional Products Inc Vol #: 167
LET 18134 Perrigo Company of South Carolina Vol #: 167
LET 18135 Perrigo Company of South Carolina Vol #: 167
LET 18136 Pharmavite LLC Vol #: 167
LET 18137 Perrigo Company of South Carolina Vol #: 167
LET 18138 JOL Management Vol #: 167
LET 18139 Nutriex LC Vol #: 167
LET 18140 Nutrition Now Inc Vol #: 167
2003D-0478 Guidance on Marketed Unapproved Drugs Compliance Policy Guide
EC 31 Mrs. JANET RITTER Vol #: 5
2004E-0425 Patent Extension for Plenaxis (abarelix), U.S. Patent No. 5,843,901
LET 4 FDA/CDER to the U.S. Patent and Trademark Office Vol #: 1
2004E-0427 Patent Extension for Ketek (telithromycin), U.S. Patent No. 5,635,485
LET 4 FDA/CDER to the U.S. Patent and Trademark Office Vol #: 1
2005D-0195 Guidance for Industry and FDA Staff; The Mammography Quality Standards Act Final Regulations: Modifications and Additions to Policy Guidance Help System #9
EC 8 New York University-School of Medicine Vol #: 1
2005E-0253 Patent Extension Application for TARCEVA (erlotinib hydrochloride), U.S. Patent No. 5,747,498
LET 4 FDA/CDER to the U.S. Patent and Trademark Office Vol #: 1
2006D-0331 Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
EC 2 Ms. Debra Jo Endres-Ard Vol #: 1
EC 3 La Cesta Consultants, LLC Vol #: 1
EC 4 Citizen of The United States Vol #: 1
EC 5 R Adams Cowley Shock Trauma Center Vol #: 1
EC 6 Ms. Elaine Daly Vol #: 1
EC 7 Boston Universtity School of Medicine Vol #: 1
EC 8 Ms. Debra Jo Endres-Ard Vol #: 1
EC 9 Wisconsin State EMS Medical Director Vol #: 1
EC 10 Ms. Elaine Daly Vol #: 1
EC 11 Citizen Vol #: 1
2006E-0008 Patent Extension Application for DRAXXIN (tulathromycin), U.S. Patent No. 6,420,536
LET 4 FDA/CDER to the U.S. Patent and Trademark Office Vol #: 1
2006E-0031 Patent Extension Application for CLOLAR (clofarabine), U.S. Patent No. 5,661,136
LET 5 FDA/CDER to the U.S. Patent and Trademark Office Vol #: 1
2006E-0050 Patent Extension Application for BYETTA (exenatide injection), U.S. Patent No. 5,424,286
LET 4 FDA/CDER to the U.S. Patent and Trademark Office Vol #: 1
2006E-0204 Patent Extension Application for NATRECOR (nesiritride) for U.S. Patent No. 5,114,923
LET 4 FDA/CDER to the U.S. Patent and Trademark Office Vol #: 1
2006P-0223 Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
EC 591 Dr. Juan Hernandez MD Vol #: 5
EC 592 Mr. Justin Wassel Vol #: 5
EC 593 Mr. Richard Cox Vol #: 5
EC 594 Mr. Michael Blaine Vol #: 5
EC 595 Mr. Michael Bredeweg Vol #: 5
EC 596 Mrs. Barbara Rebentisch Vol #: 5
EC 597 RN Vol #: 5
EC 598 Mrs. Julie Hering Vol #: 5
EC 599 Mr. Tucker Wilson Vol #: 5
EC 600 Mr. Harold Hughes Vol #: 5
EC 601 church of Christ Vol #: 5
EC 602 Mr. Bruce Dougherty Vol #: 5
EC 603 Ms. Joy Williams Vol #: 5
EC 604 Mrs. Kathleen Elsie Gibbs Vol #: 5
EC 605 Mrs. Anita Becker Vol #: 5
EC 606 KJB Investments Vol #: 5
EC 607 Mr. Johnny Lamb Vol #: 5
EC 608 Mrs. Dawne McGrath Vol #: 5
EC 609 Miss. Monica Baird Vol #: 5
EC 610 Mrs. Drucilla White Vol #: 5
EC 611 Mr. Michael Ciha Vol #: 5
EC 612 Mr. Thomas Olsen Vol #: 5
EC 613 Mr. Kenneth Earl Vol #: 5
EC 614 Ms. Nancy Vicalvi Vol #: 5
EC 615 Sptoswood Right to Life Vol #: 5
EC 616 Mr. Arnold Joubert Vol #: 5
EC 617 N/A Vol #: 5
EC 618 Mr. Earl Takes Vol #: 5
EC 619 Mr. Thomas Nosacek Vol #: 5
EC 620 Mrs. carol hadzicki Vol #: 5
EC 621 Mrs. Carolyn Voegtlin Vol #: 5
EC 622 Mrs. Carla Sherman Vol #: 5
EC 623 Mrs. Lydia Archer Vol #: 5
EC 624 Retired R.N. Vol #: 5
EC 625 Mr. Maurice Kienenberger Vol #: 5
EC 626 Ms. Angela Webb Vol #: 5
EC 627 Dr. Murray Brown Vol #: 5
EC 628 Mrs. Grace Harman Vol #: 5
EC 629 Mrs. Carolyn Kapp Vol #: 5
EC 630 Health South Vol #: 5
EC 631 Mr. Ben Nation Vol #: 5
EC 632 Mr. Daniel Fowler Vol #: 5
EC 633 none Vol #: 5
EC 634 Mrs. Lisa Metzen Vol #: 5
EC 635 Ms. Joan Hollman Vol #: 5
EC 636 Mrs. Clarissa Bohrer Vol #: 5
EC 637 Mrs. Jennifer Junio Vol #: 5
EC 638 Mr. Jeff Glenn Vol #: 5
EC 639 Ms. Fran Wilson Vol #: 5
EC 640 Mr. Aldon Schaap Vol #: 5
EC 641 Mrs. Annette Johnsen Vol #: 5
EC 642 none Vol #: 5
EC 643 Mrs. Louise Williams Vol #: 5
EC 644 Mr. Paul Mossey Vol #: 5
EC 645 Mr. Guy Stephenson Vol #: 5
EC 646 Mrs. Geraldine Duzenack Vol #: 5
EC 647 Mrs. Grace Hefflinger Vol #: 5
EC 648 Mr. Allen Lakner Vol #: 5
EC 649 Mrs. Dawn Speer Vol #: 5
EC 650 Mrs. Grace Hefflinger Vol #: 5
EC 651 Citizen Vol #: 5
EC 652 N/A Vol #: 5
EC 653 Dr. Peter Redburn Vol #: 5
EC 654 Miss. John McNamara Vol #: 5
EC 655 Miss. Elena Hung Vol #: 5
EC 656 Grassfire.orgalliance Vol #: 5
EC 657 n/a Vol #: 5
EC 658 Mr. David Paul Xavier Burch Vol #: 5
EC 659 none Vol #: 5
EC 660 NA Vol #: 5
EC 661 Mrs. Jeri B. Miller Vol #: 5
EC 662 Mrs. Danita Scheid Vol #: 5
EC 663 Mrs. Nancy Martinez Vol #: 5
EC 664 Mrs. Bonnie Holt Vol #: 5
EC 665 Mrs. nicki wharton Vol #: 5
EC 666 Mr. Kenneth LeRoy Vol #: 5
EC 667 Mrs. Patricia Burton Vol #: 5
EC 668 Dr. muhhamad waseem Vol #: 5
EC 669 Mr. Alan Haggard Vol #: 5
EC 670 Mrs. Annette Unger Vol #: 5
EC 671 Mrs. kathleen oakley Vol #: 5
EC 672 Ms. Pauline Anderberg Vol #: 5
EC 673 Ms. Patricia Staege Vol #: 5
EC 674 Miss. Jessica Hoffman Vol #: 5
EC 675 Dr. Judith Edwards Vol #: 5
EC 676 Ms. Eileen Ratigan Vol #: 5
EC 677 Ms. Dagmar Hoffmann Vol #: 5
EC 678 REGISTERED NURSE Vol #: 5
EC 679 Mr. Duane Oelrich Vol #: 5
EC 680 Mrs. Michelle Winder Vol #: 5
EC 681 Mr. Mark McAdow Vol #: 5
EC 682 Mr. Greg Schneider Vol #: 5
EC 683 Mrs. Helen Nixon Vol #: 5
EC 684 Mrs. Marie Barney Vol #: 5
2006P-0372 Determine whether Mepron (atovaquone) Tablets, 250 mg, has been voluntarily withdrawn from sale for safety or efficacy reasons
ACK 1 FDA/DDM to Lachman Consultant Services, Inc. Vol #: 1
CP 1 Lachman Consultant Services, Inc. Vol #: 1
2006V-0373 Laser Light Show
ACK 1 FDA /DDM to Griffith Observatory, (Oschin Planetarium) Vol #: 1
VAR 1 Griffith Observatory, (Oschin Planetarium) Vol #: 1

Page created on October 4, 2006 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management